keyword
https://read.qxmd.com/read/36624391/tobacco-alcohol-cannabis-and-illicit-drug-use-and-their-association-with-cd4-cd8-cell-count-ratio-in-people-with-controlled-hiv-a-cross-sectional-study-anrs-co3-aquivih-na-qualiv
#21
JOURNAL ARTICLE
Sophie Devos, Fabrice Bonnet, Mojgan Hessamfar, Didier Neau, Marc-Olivier Vareil, Olivier Leleux, Charles Cazanave, Nicolas Rouanes, Pierre Duffau, Estibaliz Lazaro, François Dabis, Linda Wittkop, Diana Barger
BACKGROUND: To evaluate drug use (alcohol, tobacco, cannabis and other drugs) and its association with mean CD4/CD8 T cell count ratio, a marker of chronic inflammation, in virally suppressed people living with HIV-1 (PLWH) in Nouvelle Aquitaine, France. METHODS: A multi-centric, cross-sectional analysis was conducted in 2018-19 in the QuAliV study-ANRS CO3 AQUIVIH-NA cohort. Tobacco, alcohol, cannabis, and other drug use (poppers, cocaine, amphetamines, synthetic cathinones, GHB/GBL) were self-reported...
January 9, 2023: BMC Infectious Diseases
https://read.qxmd.com/read/36617267/sodium-oxybate-for-alcohol-dependence-a-network-meta-regression-analysis-considering-population-severity-at-baseline-and-treatment-duration
#22
JOURNAL ARTICLE
Julien Guiraud, Giovanni Addolorato, Henri-Jean Aubin, Sylvie Bachelot, Philippe Batel, Andrea de Bejczy, Amine Benyamina, Fabio Caputo, Monique Couderc, Maurice Dematteis, Anna E Goudriaan, Antoni Gual, Sylvie Lecoustey, Otto-Michael Lesch, Icro Maremmani, David J Nutt, François Paille, Pascal Perney, Jürgen Rehm, Benjamin Rolland, Bruno Scherrer, Nicolas Simon, Bo Söderpalm, Lorenzo Somaini, Wolfgang H Sommer, Rainer Spanagel, Henriette Walter, Wim van den Brink
AIMS: The estimated effect of sodium oxybate (SMO) in the treatment of alcohol dependence is heterogeneous. Population severity and treatment duration have been identified as potential effect modifiers. Population severity distinguishes heavy drinking patients with <14 days of abstinence before treatment initiation (high-severity population) from other patients (mild-severity population). Treatment duration reflects the planned treatment duration. This study aimed to systematically investigate the effect of these potential effect moderators on SMO efficacy in alcohol-dependent patients...
January 6, 2023: Alcohol and Alcoholism
https://read.qxmd.com/read/36527909/adverse-outcomes-of-ghb-use-analysis-of-ambulance-attendances-in-metropolitan-and-regional-victoria
#23
JOURNAL ARTICLE
Rowan P Ogeil, Agatha Faulkner, Naomi Beard, Jessica J Killian, Shalini Arunogiri, Vicky Phan, James Wilson, Karen Smith, Dan I Lubman, Debbie Scott
BACKGROUND: Gamma-hydroxybutyrate (GHB) use and attributable harms have been increasing in Australia, however changes over time, including the impact of COVID-19 lockdowns and restrictions on harms requiring an ambulance attendance, are unknown. This study utilised a novel population-based surveillance system to identify the types of GHB-related harms between January 2018 and 31 December 2021 in Victoria, Australia. METHODS: A cross-sectional, retrospective analysis of all GHB-related ambulance attendances between January 2018 and 31 December 2021 in Victoria, Australia was undertaken...
December 14, 2022: International Journal on Drug Policy
https://read.qxmd.com/read/36505956/withdrawal-of-gamma-hydroxybutyrate-in-a-saudi-male-patient-a-case-report
#24
Ibtihal M Alattas, Sultan A Alwajeeh, Osama O Alamoudi, Abdulmajeed H Alzahrani, Badria A Alhatali
Gamma-hydroxybutyrate (GHB) is a central nervous system (CNS) depressant with limited clinical use but has been misused in the last few decades. During intoxication, the patient may develop CNS depression and may have agitation, while during withdrawal, the patient can present with severe agitation or delirium. Here, we report the case of a 30-year-old Saudi male patient who was brought by his brother to the emergency department (ED) with agitation and delirium. The patient's friend stated the patient had been misusing GHB mixed with alcohol for the last seven months, with the last use occurring 24 hours before the ED presentation...
December 2022: Curēus
https://read.qxmd.com/read/36475433/characteristics-of-poisonings-involving-ketamine-in-the-united-states-2019-2021
#25
JOURNAL ARTICLE
Joseph J Palamar, Nicole D Fitzgerald, David J Grundy, Joshua C Black, Jennifer S Jewell, Linda B Cottler
BACKGROUND: The use of ketamine, a controlled dissociative anesthetic, has become more widespread in recent years with recreational/nonmedical use increasing and ketamine becoming more widely available in clinics to treat depression. AIMS: We examined recent trends in adverse effects related to ketamine use. METHODS: US National Poison Control data were examined, focusing on ketamine exposures among those aged ⩾13 between 2019 and 2021 ( n  = 758)...
August 2023: Journal of Psychopharmacology
https://read.qxmd.com/read/36465301/differences-between-users-and-addiction-medicine-experts-harm-and-benefit-assessments-of-licit-and-illicit-psychoactive-drugs-input-for-psychoeducation-and-legalization-restriction-debates
#26
JOURNAL ARTICLE
Udo Bonnet, Michael Specka, Ann-Kristin Kanti, Norbert Scherbaum
BACKGROUND: There is a lack of benefit/harm assessments of illicit and licit psychoactive substances performed by substance-dependent users in comparison to addiction medicine experts. METHODS: We extended the analyses of substance harm/benefit assessments of German addiction medicine experts ( N = 101), in parts reported recently in this journal [doi.org/10.3389/fpsyt.2020.59219], by the perspectives of substance-addicted persons. The same questionnaire as used for the abovementioned "experts-study" was handed out to inpatient detoxification or rehab treatment seeking German substance-dependent adults ( N = 117) for a subsequent structured interview about harms and benefits of 33 new and traditional psychoactive substances comprising also prescription drugs...
2022: Frontiers in Psychiatry
https://read.qxmd.com/read/36294225/substance-use-in-sexual-relationships-association-with-sexual-assertiveness-and-sexual-satisfaction
#27
JOURNAL ARTICLE
Paula López de Juan Abad, Ana Isabel Arcos-Romero
BACKGROUND: The main objective was to examine sexual assertiveness and sexual satisfaction in people who have sex under the influence of alcohol and drugs, considering the type of substance consumed, the frequency of consumption, gender, and sexual orientation. METHODS: The sample consisted of 274 adults who had sexual relationships consuming substances. A questionnaire composed of sociodemographic, sexual history and substance use items, the Sexual Assertiveness Scale and the Global Measure of Sexual Satisfaction were administered...
October 21, 2022: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/36269081/phenobarbital-to-manage-severe-gamma-hydroxybutyrate-withdrawal-a-case-series
#28
Georgia Freeman, Krista J Siefried, Darren M Roberts, Craig Rodgers, Una Nic Ionmhain, Jay Ramanathan, Nadine Ezard, Jonathan Brett
INTRODUCTION: Management of a withdrawal syndrome following cessation of regular gamma-hydroxybutyrate (GHB) use, and its precursors, can represent a clinical challenge due to rapid onset delirium and/or seizures. Severe GHB withdrawal can be characterised by persistent or worsening features despite increasing benzodiazepine doses and regular baclofen. Barbiturates, such as phenobarbital, are an appealing option in this context due to their unique GABA-A receptor action. CASE SERIES: This series describes the use of phenobarbital in 13 cases, 12 patients, across two hospitals in Sydney, Australia, with persistent or progressive GHB withdrawal despite benzodiazepine-based management...
January 2023: Drug and Alcohol Review
https://read.qxmd.com/read/36268824/correction-protection-against-chemical-submission-naked-eye-detection-of-%C3%AE-hydroxybutyric-acid-ghb-in-soft-drinks-and-alcoholic-beverages
#29
Silvia Rodríguez-Nuévalos, Ana M Costero, Pau Arroyo, José A Sáez, Margarita Parra, Félix Sancenón, Ramón Martínez-Máñez
Correction for 'Protection against chemical submission: naked-eye detection of γ-hydroxybutyric acid (GHB) in soft drinks and alcoholic beverages' by Silvia Rodríguez-Nuévalos et al. , Chem. Commun. , 2020, 56 , 12600-12603, https://doi.org/10.1039/D0CC05387B.
October 21, 2022: Chemical Communications: Chem Comm
https://read.qxmd.com/read/35914751/acute-sodium-oxybate-intoxication-a-case-report-and-review-of-the-literature
#30
JOURNAL ARTICLE
Guillaume Drevin, Marie Briet, Severine Ferec, Julien Demiselle, François Beloncle, Chadi Abbara
PURPOSE: Despite a better safety profile than illicit γ-hydroxybutyric acid (GHB) and other GHB-analogs, sodium oxybate continues to raise serious concerns regarding clinical safety. In this study, the authors report the case of near-fatal intoxication involving sodium oxybate-alcohol combination in a 40-year-old woman. In addition, a review of the literature on published cases of intoxication involving this pharmaceutical form of GHB was conducted. A 40-year-old woman was admitted to the intensive care unit in a coma following voluntary ingestion of 18 g of sodium oxybate and alcohol...
July 20, 2022: Therapeutic Drug Monitoring
https://read.qxmd.com/read/35899729/-impact-of-the-covid-19-pandemic-on-recreational-drug-intoxications
#31
JOURNAL ARTICLE
Dena Akhoundzadeh, Parisa Kamali, Bas van den Bogaard, Femke M J Gresnigt
OBJECTIVE: To investigated the impact of the lockdown during the COVID-19 pandemic, since March 2020, on the occurrence and characteristics of recreational drug intoxications in the Emergency Department (ED), compared to previous years. DESIGN: Retrospective cohort study METHOD: Patients ≥ 18 years old who presented to the ED of OLVG hospital in Amsterdam with recreational drug intoxication(s), with or without alcohol, were divided into the pre-COVID-19-period (January 2017 to February 2020), and the COVID-19-period (March to December 2020)...
July 6, 2022: Nederlands Tijdschrift Voor Geneeskunde
https://read.qxmd.com/read/35867479/flumazenil-partially-reverses-gamma-hydroxybutyrate-ghb-induced-coma-a-case-report
#32
JOURNAL ARTICLE
Shiao-Yu Chen, Feng-Yuan Chu, Chih-Yu Yang, Der-Cherng Tarng
No abstract text is available yet for this article.
July 22, 2022: American Journal of Drug and Alcohol Abuse
https://read.qxmd.com/read/35796481/sodium-oxybate-for-the-maintenance-of-abstinence-in-alcohol-dependent-patients-an-international-multicenter-randomized-double-blind-placebo-controlled-trial
#33
JOURNAL ARTICLE
Julien Guiraud, Giovanni Addolorato, Mariangela Antonelli, Henri-Jean Aubin, Andrea de Bejczy, Amine Benyamina, Roberto Cacciaglia, Fabio Caputo, Maurice Dematteis, Anna Ferrulli, Anna E Goudriaan, Antoni Gual, Otto-Michael Lesch, Icro Maremmani, Antonio Mirijello, David J Nutt, François Paille, Pascal Perney, Roch Poulnais, Quentin Raffaillac, Jürgen Rehm, Benjamin Rolland, Claudia Rotondo, Bruno Scherrer, Nicolas Simon, Katrin Skala, Bo Söderpalm, Lorenzo Somaini, Wolfgang H Sommer, Rainer Spanagel, Gabriele A Vassallo, Henriette Walter, Wim van den Brink
BACKGROUND: Sodium oxybate (SMO) has been shown to be effective in the maintenance of abstinence (MoA) in alcohol-dependent patients in a series of small randomized controlled trials (RCTs). These results needed to be confirmed by a large trial investigating the treatment effect and its sustainability after medication discontinuation. AIMS: To confirm the SMO effect on (sustained) MoA in detoxified alcohol-dependent patients. METHODS: Large double-blind, randomized, placebo-controlled trial in detoxified adult alcohol-dependent outpatients (80% men) from 11 sites in four European countries...
July 7, 2022: Journal of Psychopharmacology
https://read.qxmd.com/read/35755407/increased-voluntary-alcohol-consumption-in-mice-lacking-gaba-b-1-is-associated-with-functional-changes-in-hippocampal-gaba-a-receptors
#34
JOURNAL ARTICLE
Gabriele Floris, Gino Paolo Asuni, Giuseppe Talani, Francesca Biggio, Maria Giuseppina Pisu, Mary Tresa Zanda, Liliana Contu, Elisabetta Maciocco, Mariangela Serra, Paolo Follesa
Gamma-aminobutyric acid type B receptor (GABAB R) has been extensively involved in alcohol use disorders; however, the mechanisms by which this receptor modulates alcohol drinking behavior remain murky. In this study, we investigate alcohol consumption and preference in mice lacking functional GABAB R using the 2-bottle choice paradigm. We found that GABAB(1) , knockout (KO), and heterozygous (HZ) mice drank higher amounts of an alcoholic solution, preferred alcohol to water, and reached higher blood alcohol concentrations (BACs) compared to wild-type (WT) littermates...
2022: Frontiers in Behavioral Neuroscience
https://read.qxmd.com/read/35597734/perspectives-on-the-pharmacological-management-of-alcohol-use-disorder-are-the-approved-medications-effective
#35
REVIEW
Mariangela Antonelli, Luisa Sestito, Claudia Tarli, Giovanni Addolorato
INTRODUCTION: In the last decades, many medications have been tested for the treatment of Alcohol Use Disorder (AUD). Among them, disulfiram, acamprosate, naltrexone, nalmefene, sodium oxybate and baclofen have been approved in different countries, with different specific indications. Topiramate is not approved for the treatment of AUD, however, it is suggested as a therapeutic option by the American Psychiatric Association for patients who do not tolerate or respond to approved therapies...
September 2022: European Journal of Internal Medicine
https://read.qxmd.com/read/35523571/alcohol-and-drug-use-during-sex-and-its-association-with-sexually-transmitted-infections-a-retrospective-cohort-study-among-young-people-aged-under-25-years-visiting-dutch-sti-clinics
#36
JOURNAL ARTICLE
Ymke J Evers, Kiki P L Op den Camp, Mischa Lenaers, Nicole H T M Dukers-Muijrers, Christian J P A Hoebe
INTRODUCTION: Alcohol use and drug use are common behaviours among young people. STI positivity is higher in young people than in people aged above 25 years. While there is an increasing amount of knowledge about drug use during sex among men who have sex with men (MSM), data on this behaviour among young women and heterosexual men are scarce. Therefore, this study aims to assess the proportion and characteristics of women and heterosexual men aged under 25 years reporting alcohol and/or drug use during sex and its association with STI positivity...
March 2023: Sexually Transmitted Infections
https://read.qxmd.com/read/35484175/randomised-trial-of-intravenous-thiamine-and-or-magnesium-sulphate-administration-on-erythrocyte-transketolase-activity-lactate-concentrations-and-alcohol-withdrawal-scores
#37
RANDOMIZED CONTROLLED TRIAL
Donogh Maguire, Alana Burns, Dinesh Talwar, Anthony Catchpole, Fiona Stefanowicz, David P Ross, Peter Galloway, Alastair Ireland, Gordon Robson, Michael Adamson, Lesley Orr, Joanna-Lee Kerr, Xenofon Roussis, Eoghan Colgan, Ewan Forrest, David Young, Donald C McMillan
Alcohol withdrawal syndrome (AWS) occurs in 2% of patients admitted to U.K. hospitals. Routine treatment includes thiamine and benzodiazepines. Laboratory studies indicate that thiamine requires magnesium for optimal activity, however this has not translated into clinical practice. Patients experiencing AWS were randomized to three groups: (group 1) thiamine, (group 2) thiamine plus MgSO4 or (group 3) MgSO4 . Pre- and 2-h post-treatment blood samples were taken. AWS severity was recorded using the Glasgow Modified Alcohol Withdrawal Score (GMAWS)...
April 28, 2022: Scientific Reports
https://read.qxmd.com/read/35415886/easy-and-convenient-millimole-scale-synthesis-of-new-potential-biomarkers-for-gamma-hydroxybutyric-acid-ghb-intake-feasible-for-analytical-laboratories
#38
JOURNAL ARTICLE
Christian Steuer, Dario Quattrini, Justine Raeber, Philipp Waser, Andrea E Steuer
New biomarkers indicating the abuse of drugs and alcohol are still of major interest for clinical and forensic sciences. The endogenous neurotransmitter and approved drug, gamma-hydroxybutyric acid (GHB), is often illegally used for drug-facilitated crimes by spiking GHB into alcoholic beverages. Analytical detection windows of only 6 h in blood and 12 h in urine are often too short to provide reliable proof of GHB ingestion. Therefore, new biomarkers are needed to prove exogenous GHB administration. Previously, amino acid GHB conjugates were discovered in an untargeted metabolomics screening and fatty acid esters with GHB were recently discussed as promising biomarkers to enlarge the analytical detection time windows...
August 2022: Drug Testing and Analysis
https://read.qxmd.com/read/35368091/smartphone-based-colorimetric-determination-of-gamma-butyrolactone-and-gamma-hydroxybutyrate-in-alcoholic-beverage-samples
#39
JOURNAL ARTICLE
Anselmo Procida, Kevin C Honeychurch
Gamma-hydroxybutyrate (GBH) is a popular recreational drug. Its strong sedative and amnesic effects have led to drug-facilitated sexual assaults, poisonings, overdose, and death. As a result, legislation has restricted its availability leading to GHB, consumers switching to its pro-drug, gamma-butyrolactone (GBL). Consequently, there is a growing need for methods capable of their determination in complex samples such as beverages. Previous studies have shown the possibility to colorimetrically qualitatively determine both GBH and GBL by the formation of the lactone and its reaction with hydroxylamine and ferric chloride to give a purple-colored complex...
April 3, 2022: Journal of Forensic Sciences
https://read.qxmd.com/read/35133639/novel-agents-for-the-pharmacological-treatment-of-alcohol-use-disorder
#40
REVIEW
Elizabeth M Burnette, Steven J Nieto, Erica N Grodin, Lindsay R Meredith, Brian Hurley, Karen Miotto, Artha J Gillis, Lara A Ray
Alcohol use disorder (AUD) is a highly prevalent but severely under-treated disorder, with only three widely-approved pharmacotherapies. Given that AUD is a very heterogeneous disorder, it is unlikely that one single medication will be effective for all individuals with an AUD. As such, there is a need to develop new, more effective, and diverse pharmacological treatment options for AUD with the hopes of increasing utilization and improving care. In this qualitative literature review, we discuss the efficacy, mechanism of action, and tolerability of approved, repurposed, and novel pharmacotherapies for the treatment of AUD with a clinical perspective...
February 2022: Drugs
keyword
keyword
86359
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.